8-(Trifluoromethyl)-1,2,3,4-tetrahydroquinoline, 95%, 100mg

4-(5-Bromo-pyrimidin-2-yloxy)-benzonitrile, 97.0%, 250mg

N-(4-FLUOROPHENYL)-4-PHENYL-1,3-THIAZOL-2-AMINE, 95%, 5mg

5,7-Dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid hydrochloride, 97%, 100mg

Tetrakis(4-carboxyphenoxymethyl)methane, 97%, 100mg

(S)-5-Fluoro-2,3-dihydro-1H-inden-1-aminehydrochloride, 95.0%, 1g

ETHYL-3-PHENYL PYRAZOLE-4-CARBOXYLATE, 95.0%, 1g

4-(3-(Trimethoxysilyl)propyl)morpholine, 98.0%, 1g

Xphos Pd G4, ?98.0%, 250mg

1-Methyl-2-oxo-1,2-dihydro-quinoline-3-carbaldehyde, 95.0%, 1g

3-Methyl-4-bromopyrazole, 95.0%, 100g

GC capillary column ROTI®Cap-1701, 10 m, 0.32 mm, 0.25 µm, 1 Piece(s)

2-(2-Methoxyphenyl)acetophenone, 97.0%, 2g